SEC Form 4 · accession 0001019687-15-002358

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director · 10% Owner

Period of report

Jun 8, 2015

Accepted (ET)

Jun 10, 2015 · 9:10 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000748592

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Jun 8, 2015	P	5,000	$0.2738	A	20,608,982	I	See Footnote
Common Stock^F1	Jun 8, 2015	P	5,000	$0.2749	A	20,613,982	I	See Footnote
Common Stock^F1	Jun 8, 2015	P	5,000	$0.2701	A	20,618,982	I	See Footnote
Common Stock^F1	Jun 8, 2015	P	10,000	$0.2748	A	20,628,982	I	See Footnote
Common Stock^F1	Jun 8, 2015	P	5,000	$0.2734	A	20,633,982	I	See Footnote
Common Stock^F1	Jun 9, 2015	P	5,000	$0.2799	A	20,638,982	I	See Footnote
Common Stock^F1	Jun 9, 2015	P	5,000	$0.2778	A	20,643,982	I	See Footnote
Common Stock^F1	Jun 10, 2015	P	5,000	$0.2699	A	20,648,982	I	See Footnote
Common Stock^F1	Jun 10, 2015	P	5,000	$0.2734	A	20,653,982	I	See Footnote
Common Stock^F1	Jun 10, 2015	P	5,000	$0.2618	A	20,658,982	I	See Footnote
Common Stock^F1	Jun 10, 2015	P	5,000	$0.2693	A	20,663,982	I	See Footnote
Common Stock^F1	Jun 10, 2015	P	5,000	$0.2655	A	20,668,982	I	See Footnote
Common Stock	holding	—	—		—	530,000	D

No Table II lines on this filing.

F1These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.